Valuation: Tempus AI, Inc.

Market Cap 13.12B 11.23B 10.51B 9.62B 18.06B 1,255B 18.3B 124B 48.43B 630B 49.25B 48.18B 2,085B P/E 2026 *
-51x
P/E 2027 * -53.7x
Enterprise Value 13.65B 11.69B 10.94B 10.01B 18.79B 1,306B 19.04B 129B 50.39B 656B 51.24B 50.13B 2,169B EV / Sales 2026 *
8.55x
EV / Sales 2027 * 6.88x
Free-Float
61.2%
Yield 2026 *
-
Yield 2027 * -
1 day+10.30%
1 week+40.13%
Current month+66.32%
1 month+50.48%
3 months+61.22%
6 months+19.47%
Current year+4.72%
1 week 4.9
Extreme 4.895
6.32
1 month 3.48
Extreme 3.485
6.32
Current year 3.48
Extreme 3.485
6.32
1 year 3.48
Extreme 3.485
6.32
3 years 3.48
Extreme 3.485
6.32
5 years 3.48
Extreme 3.485
6.32
10 years 3.48
Extreme 3.485
6.32
Manager TitleAgeSince
Chief Executive Officer 56 2015-07-31
Director of Finance/CFO 40 2017-07-31
Chief Administrative Officer 55 2020-05-31
Director TitleAgeSince
Chairman 56 2015-07-31
Director/Board Member 53 2019-10-28
Director/Board Member 74 2017-08-31
Change 5-day change 1-year change 3-year change Capi.($)
+10.30%+40.13% - - 12.03B
+1.09%+5.26%+4.44%+26.03% 51.22B
-1.07%+2.82%+474.18%+601.24% 45.38B
+1.47%+9.79%+40.15%+21.21% 42.15B
+1.44%+7.77%+19.27%+90.94% 41.97B
-0.93%-4.33%+17.87%+51.96% 31.95B
+1.32%+7.30%+36.93%+152.36% 17.1B
-0.60%+1.93% - - 16.73B
+0.03%+3.41%+7.12%+35.49% 14.76B
+1.28%+5.41%+91.01%+46.93% 13.91B
Average +1.43%+3.68%+86.37%+128.27% 30.58B
Weighted average by Cap. +0.89%+3.55%+103.78%+150.02%

Financials

2026 *2027 *
Net sales 1.6B 1.37B 1.28B 1.17B 2.2B 153B 2.23B 15.12B 5.9B 76.75B 6B 5.87B 254B 1.97B 1.69B 1.58B 1.45B 2.71B 188B 2.75B 18.65B 7.27B 94.68B 7.4B 7.24B 313B
Net income -250M -214M -201M -184M -345M -23.96B -349M -2.37B -925M -12.03B -940M -920M -39.81B -245M -210M -197M -180M -338M -23.48B -342M -2.32B -906M -11.8B -921M -901M -39.01B
Net Debt 531M 455M 425M 389M 731M 50.78B 740M 5.03B 1.96B 25.51B 1.99B 1.95B 84.38B 429M 368M 344M 315M 591M 41.09B 599M 4.07B 1.59B 20.64B 1.61B 1.58B 68.28B
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Employees
3,800
Date Price Change Volume
26-08-21 US$6.320 +10.30% 1,755
26-08-20 US$5.730 +9.35% 1,722
26-08-19 US$5.240 +16.19% 1,515
26-08-14 US$4.510 -4.85% 1,404
26-08-13 US$4.740 +0.96% 301
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
72.69USD
Average target price
63.36USD
Spread / Average Target
-12.84%

Quarterly revenue - Rate of surprise